Swine flu ADR portal

on the 1 December 2009

The MHRA's special web-based system for reporting adverse reactions to swine flu medicines has been extended. The Swine Flu ADR Portal can now be used to notify the MHRA of adverse events following exposure to vaccines against H1N1 (Celvapan and Pandemrix) or seasonal flu, in addition to reporting adverse reactions to Tamiflu and Relenza.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

More from MIMS

Experts urge vitamin D supplementation and call for research into possible COVID-19 benefits

Experts urge vitamin D supplementation and call for research into possible COVID-19 benefits

People are being urged to take vitamin D supplements...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

New rapidly acting insulin launched

New rapidly acting insulin launched

Lyumjev is a new 'ultra rapidly acting' formulation...